Igor Udod
About Igor Udod
Igor Udod is a Senior ARD Scientist at QuVa Pharma, Inc. in Bloomsbury, NJ, with extensive experience in analytical techniques and method validation in the pharmaceutical industry.
Work at QuVa Pharma
Igor Udod has been employed at QuVa Pharma, Inc. as a Senior ARD Scientist since 2019. In this role, he has implemented a Method Validation and Training Program specifically for Raman RM ID technology within the pharmaceutical industry. His contributions focus on enhancing analytical processes and ensuring compliance with industry standards.
Previous Experience in the Pharmaceutical Industry
Prior to his current position, Udod worked at Teva Pharmaceuticals as a Manager from 1997 to 2009, accumulating 12 years of experience. He also served as a Visiting Scientist at Allied Signal Inc/Honeywell Inc from 1997 to 2001, where he worked as a contractor. This extensive background in the pharmaceutical sector has equipped him with a comprehensive understanding of various analytical and quality control processes.
Education and Expertise
Udod studied at Lomonosov Moscow State University (MSU), where he earned both a B.S. and M.S. in Chemistry from 1983 to 1988, followed by a Ph.D. in Chemistry from 1988 to 1994. His educational background provides a strong foundation for his expertise in analytical techniques and quality assurance practices.
Analytical Techniques and Quality Assurance
Igor Udod possesses extensive experience with a variety of analytical techniques, including GC, HPLC, UPLC, LC/GC-MS, ICP-MS, and more. He is well-versed in CAPA, Change Controls, and OOS investigation systems such as LIMS and Trackwise. His experience also includes the analytical components of ANDA submissions, encompassing QOS, Development reports, and Method Validation reports.
Development of Quality Services Laboratory Operations
Udod has developed operations for a Quality Services Laboratory that provides forensic services, including non-destructive complaint sample analysis and counterfeit investigations. This initiative highlights his commitment to advancing quality assurance and analytical capabilities within the pharmaceutical industry.